Latest Innovations in Mental Health Therapy

Therabot just passed the world’s first clinical trial for an AI therapy chatbot. Developed by Dartmouth over 5 years, it’s already delivering real, measurable results that could change the face of mental health care. But it wasn’t always this way. When Therabot was first created, its early versions were a disaster: - One chatbot expressed suicidal thoughts. - Another blamed everything on your parents by question five. But the team at Dartmouth didn’t give up — they spent 3 years and 100+ people crafting custom training data from scratch to get it right. And it paid off. The results of the clinical trial? 👉 A 51% reduction in depression symptoms among participants. 👉 People with moderate anxiety saw their symptoms drop to “mild” levels. 👉 Some no longer met diagnostic criteria for anxiety or depression. 👉 And most surprisingly: Participants rated their connection to Therabot as equal to a human therapist. So what matters now? It works. It’s scalable. It’s always available, unlike human therapists who book months out. But if you ask me — I don’t believe it will replace human therapy anytime soon. However, with 70% of people around the world having no access to mental health care, Therabot might be their first real shot at getting the help they need. So the future of therapy won’t be 100% AI. But it could be AI-assisted, AI-augmented, and most importantly, AI-accessible. Because mental health care isn’t broken — it’s just undersupplied. And Therabot might not fix that overnight. But it’s the most science-backed step forward we’ve seen in years. So I’m hopeful. What’s your take on AI therapists? Could they be the solution for those who currently don’t have access to mental health care? #entrepreneurship #healthtech #AI #innovation

Rewiring the Mind: The Evolution of TMS from Theory to Rapid-Response Therapy Transcranial Magnetic Stimulation (TMS) has moved from a niche neurological concept to a cornerstone of modern psychiatry. By using electromagnetic induction to non-invasively modulate neuronal excitability, we are no longer just theorizing about brain plasticity—we are actively programming it. 🧠 The most significant shift in 2026 is the transition from conventional, multi-week "rTMS" protocols to accelerated neuromodulation. Innovations like the SAINT protocol (Stanford Neuromodulation Therapy) have revolutionized clinical timelines, condensing 30–36 sessions of treatment into a high-intensity, five-day schedule. By using fMRI data and machine learning to personalize the "target" on a patient’s dorsolateral prefrontal cortex, we have reached remission rates as high as 80–90% for treatment-resistant depression in under three days. ⚡️ Beyond depression and OCD, the horizon of TMS is expanding into the "black box" of neurology. Researchers are now observing cellular-level changes in real-time, documenting how these magnetic pulses restore synaptic scaffolding (dendritic spines) in the prefrontal cortex. This is moving us toward a future where we treat addiction, chronic neuropathic pain, and even neurodegenerative markers with the same precision we once reserved for pharmacology. 🔬 As we look toward the 2033 growth forecasts, the integration of multi-modal systems—combining TMS with EEG and fNIRS—is the next frontier. We aren't just stimulating; we are listening to the brain's real-time response, creating a closed-loop system that adjusts its "dose" based on immediate cortical feedback. We are finally building a bridge between clinical psychiatry and hard physics. ⚓️ #Physics #MedicalStudent #Neuroscience #Neuromodulation #TMS #MentalHealthTech #BioPhysics #Innovation #FutureOfMedicine #NairobiTech

I’m excited and honored to share that over the past 90 days, we conducted the world’s most extensive study on AI-guided emotional support—with nearly 1,000 participants taking part. Five years ago, I believed AI would never replace human therapists—for reasons that felt obvious. Now, seeing the study results, I just hope it doesn’t—and that it serves only as a 10x multiplier: a way to extend what human therapists can do, not replace them. 📊 Key Outcomes: 🪻31 % of participants moved from poor to normal levels of well-being Anxiety ↓ 44 % Depression ↓ 17 % PTSD symptoms ↓ 33 % Substance use↓ 30 % (alcohol) Perceived need for therapy ↓ 21 % 🧪 How the Study Was Conducted Our head of Psychology Prof. Anat Shoshani conducted the study. 900+ participants were randomly divided into three groups: Control group – Received no intervention. Face-to-face intervention – 12-week, face-to-face positive psychology workshop. Kai group – Received 24/7 emotional support from Kai, our AI companion. 👉 Kai significantly outperformed both other groups on nearly every mental health metric. Every data point is a human with real struggles—someone who might’ve waited 8+ months for support, but instead got 24/7 care. What do you think? Will AI replace or enhance therapists? Comment if you’d like early access to the full study report — or to book a live demo of Kai. #MentalHealthAI #AIinHealthcare #DigitalHealth #EmotionalWellbeing #AIClinicalResearch #InsuranceInnovation #InsuranceAI #UniversityWellbeing #HealthTech #PreventiveCare #AItherapy

Modern Therapeutic Interventions Every Psychologist Must Know Because therapy isn’t what it used to be; it’s evolving, just like the human mind. In today’s rapidly shifting psychological landscape, clients are more informed, diverse, and complex than ever. A therapist’s toolkit must expand beyond traditional CBT and talk therapy to stay relevant and effective. Here are modern, evidence-based interventions that every forward-thinking Psychologist should be equipped with: • Polyvagal-Informed Therapy → Understand the nervous system’s role in trauma, regulation, and connection. → Use tools like breathwork, grounding, and safe cues to rewire safety responses. • Internal Family Systems (IFS) → Recognize “parts” within the client: exiles, managers, and firefighters. → Heal from within by fostering Self-leadership and compassion-based change. • Compassion-Focused Therapy (CFT) → Ideal for clients stuck in shame or harsh self-criticism. → Builds emotional regulation through self-kindness and affiliation systems. • Narrative Exposure Therapy (NET) → Especially powerful for refugees, survivors, and complex trauma cases. → Clients structure their trauma into a coherent story — creating meaning and distance. • Mindfulness-Based Somatic Practices → Go beyond traditional mindfulness into embodiment, movement & trauma release. → Techniques: Somatic Experiencing, TRE (Tension & Trauma Releasing Exercises). • ACT 2.0 (Acceptance & Commitment Therapy - Evolved) → The fusion of mindfulness, values, and committed action. → Especially helpful for those feeling “stuck” despite insight. • Digital Mental Health Integration → AI-driven mental health apps, journaling bots, and real-time mood tracking. → Use tech to augment therapy, not replace it. • Psychedelic-Assisted Psychotherapy (Emerging) → With research backing MDMA & Psilocybin for PTSD, depression & existential distress. → Ethical knowledge is a must — even if you’re not practicing it. • Eco-Therapy & Nature-Based Interventions → Acknowledge climate anxiety, digital burnout, and the healing power of nature. → Simple interventions with profound grounding impact. • Biofeedback & Neurofeedback → Real-time insights into brainwaves and physiological states. → Clients learn self-regulation in a data-driven way. Why it matters? Because therapeutic innovation isn’t a luxury; it’s a necessity. The next generation of psychologists won’t just talk; They’ll decode, rewire, regulate, and co-create healing experiences. Let’s raise the bar. Therapy 3.0 is here. ______________ Salman Khan

🧠Magnetic Minds: Synergistic Approaches with TMS🧲 TMS has revolutionized neurostimulation, but its real power emerges when combined with other cutting-edge technologies. By pairing TMS with complementary modalities, researchers and clinicians are unlocking new possibilities in mental health and cognitive enhancement. 🔹 TMS + Neurofeedback – A Closed-Loop Approach Neurofeedback trains individuals to regulate their brain activity by providing real-time feedback. When combined with TMS, this creates a powerful closed-loop system where stimulation enhances plasticity while neurofeedback fine-tunes neural adaptation. Early studies suggest this duo could optimize treatment for conditions like PTSD, ADHD, and stroke recovery (Schilberg et al., 2017). 🔹 TMS + tDCS – Dual-Mode Brain Stimulation While TMS delivers high-intensity magnetic pulses, tDCS applies a lower electrical current to modulate cortical excitability. Combining the two may enhance neuroplasticity and prolong therapeutic effects. Research indicates that using tDCS before TMS could amplify its impact on cognitive function and motor rehabilitation (Lefaucheur et al., 2021). 🔹 TMS + AI – Smarter Personalization AI-driven models are transforming TMS by analyzing patient data to optimize stimulation targets and frequencies. Rather than relying on standardized protocols, AI can predict individualized TMS responses, improving treatment efficacy for depression and beyond (Siddiqi et al., 2022). 🔹 TMS + VR Therapy – A Multisensory Boost Virtual Reality exposure therapy is a proven method for treating PTSD and anxiety. When paired with TMS, the combination enhances emotional processing and accelerates fear extinction. Clinical trials suggest this approach may improve treatment retention and long-term outcomes (Rizzo et al., 2023). 🔹 TMS + Psychedelics – Unlocking Deeper Change The combination of TMS and psychedelic-assisted therapy could be a game-changer for mental health. Psychedelics enhance neural flexibility, while TMS directs and stabilizes these changes. Early studies suggest this pairing could extend the antidepressant effects of both treatments (Carhart-Harris et al., 2022). The Future is Hybrid 🏥 TMS is no longer just a standalone intervention—it’s becoming a key player in next-generation brain therapy. By combining modalities, we may be entering an era where brain stimulation is more effective, personalized, and accessible than ever before. #BrainStimulation #TMS #Neuromodulation

We are not just listening to the brain, we are starting to understand its language. And that understanding could revolutionize how we treat neurological and psychiatric disorders. The landmark study published in Nature Biomedical Engineering “Invasive neurophysiology and whole brain connectomics for neural decoding in patients with brain implants” introduces a novel platform that merges invasive brain recordings with MRI-based connectomics. Analyzing 123 hours of data from 73 patients with epilepsy, Parkinson’s, and depression, the researchers achieved: 🧠 Generalizable movement decoders across cohorts in the US, Europe, and China. 💡 Emotion decoding through prefrontal and cingulate networks in DBS-treated depression patients. ⚡ Enhanced seizure detection in responsive neurostimulation for epilepsy. This is more than brain-computer interfacing: it's a step toward adaptive, closed-loop neurotherapies that respond dynamically to each patient’s unique neural state. 👇 Explore the full article: https://lnkd.in/dA7AQtdH #Neurotech #BCI #BrainImplants #DeepBrainStimulation #PrecisionMedicine #Connectomics #Neuroscience #Epilepsy #Parkinsons #MentalHealth #MachineLearning #NeuralDecoding #Neuroengineering #AdaptiveTherapies #Neuropsychiatry #HealthcareInnovation

I’ve posted recently about the urgent need for a paradigm shift in mental health to meet overwhelming demand and the therapist shortage (pic below). I’d like to highlight a fantastic recent example of the type of delivery innovation I’m talking about. Researchers at Rush University in Chicago completed a “massed,” virtual Cognitive Processing Therapy (CPT) intervention for traumatic stress and had fantastic results (study link below). CPT is generally provided once per week for 12 weeks, usually in individual sessions. CPT is evidence-based and has great outcomes – I’ve been treating patients with trauma individually for 10 years with CPT and can attest to this. In this case, the researchers provided CPT to 24 people at once, virtually, two sessions per day over 1 week’s time (for 10 sessions total). They found: -      Highly significant drops in both PTSD and depression scores -      96% treatment retention (greater than normal) -      A drop of 5 points on the PTSD symptom scale (PCL-5) and 3 points in depression (PHQ-9) *each day*. This is an absolutely massive effect -      Improvements were maintained at 3-month follow-up These types of interventions can reach far more people, in far more places, then we ever could just working 1:1. There’s always a need for individualized work, but we desperately need to see more innovation and research in paradigms like this if we’re going to reach everyone who needs help. Study: https://lnkd.in/gh3Z8Vxa #therapy #trauma #traumarecovery #digitalhealth #psychotherapy

2025 was a remarkable year in psychiatry not because of one breakthrough, but because of steady, meaningful progress across medications, neuromodulation, technology, and access to care. Here are 10 advances that matter for clinicians, patients, families, and health systems:        1. Esketamine as monotherapy for treatment-resistant depression Previously it had to be paired with an antidepressant. Now it can stand alone in appropriate patients, expanding options while keeping safety monitoring in place.   2. Lumateperone approved as an adjunct for major depression For people who do not respond fully to antidepressants, we now have another evidence-based add-on option with a comparatively favorable metabolic profile.        3. Interventional psychiatry continues to expand TMS received new approvals in adolescents, and at-home brain-stimulation devices are emerging. Access is increasing, while careful monitoring and ethics remain essential.         4. Clozapine barriers are reduced The clozapine REMS program was eliminated, preserving laboratory monitoring while reducing administrative burden. This is meaningful for patients with treatment-resistant schizophrenia.        5. Long-acting medications grow beyond schizophrenia Long-acting injectable risperidone now has expanded use in bipolar I disorder. These formulations address relapse driven by non-adherence.        6. Better safety clarity for ADHD treatment in young children Updated guidance strengthened warnings about extended-release stimulants in children under six, encouraging more thoughtful prescribing and closer growth monitoring.         7. Psychedelic-assisted therapies advance, cautiously Research continues to show promise for depression and PTSD, while regulators appropriately demand rigorous methods and strong patient-safety protections.         8. Measurement-based care becomes mainstream From symptom scales to drug blood levels to predictive analytics, psychiatry is becoming more data-driven, while still centering the individual patient.        9. Suicide-prevention thinking evolves Models focusing on crisis narratives, entrapment, and loss of future orientation are helping clinicians identify risk even when patients do not or cannot directly express suicidal thoughts.        10. Access, equity, and parity move to the foreground Policy, reimbursement, telehealth availability, and digital disparities are increasingly shaping who actually receives mental health care. This highlights that innovation depends not only on science, but also on systems. What stands out most is this: psychiatry in 2025 is becoming more precise, more humane, and more accessible. We are pairing neuroscience with compassion, and recognizing that outcomes depend not only on treatment itself, but also on how care is delivered.

7 Key Digital Health Therapy Developments So Far This Month: 📲 MEDICE - The Health Family acquires Selfapy, integrating its online psychotherapy courses into a multimodal approach combining pharmaceuticals, digital solutions, and nutrition. Selfapy, which accounts for 20% of Germany’s listed digital mental health apps, aims to expand access through MEDICE’s clinical network 📲 A recent study found that integrating Bluetooth-connected OneTouch blood glucose meters with digital health apps like Noom, Fitbit (now part of Google), Cecelia Health, and Welldoc led to an average A1c reduction of 0.77% over three months in individuals with type 2 diabetes, suggesting that smart glucose monitoring combined with digital therapeutics can significantly improve glycemic control 📲 Strolll ’s AR glasses gamify physiotherapy for neurological disorders like Parkinson’s, stroke, and multiple sclerosis, improving mobility and adherence to treatment. Backed by clinical trials, the technology has secured £10.35m in funding 📲 A new study on the More Stamina app shows its potential to help MS patients manage fatigue by tracking energy levels and improving daily planning. Over 60 days, users reported greater self-awareness and better communication with family and healthcare providers 📲 YBRAIN’s MINDD STIM, a non-invasive neuromodulation device for depression, showed promising early results in a clinical study on perinatal depression, with significant symptom reduction after six weeks. With antidepressants often avoided in pregnancy, MINDD STIM could provide a safe, drug-free option 📲 MedRhythms, Inc. has secured FDA listing for Movive™, a prescription digital therapeutic that uses rhythmic music and sensor-based feedback to support gait rehabilitation in Parkinson’s patients, bringing clinically validated neuro music therapy into the home for broader, easier access 📲 Sidekick Health launches MENO! App, a CE-marked digital therapeutic for menopause, offering cognitive behavioral therapy as a non-hormonal alternative to hormone therapy. A 12-week clinical study in Germany aims to validate its effectiveness 👇Links to relevant articles in comments below #DigitalHealth #DTx